TAKEDA PHARMA A/S
CVR 16406899 · Public limited company (A/S) · Active · Low risk
TAKEDA PHARMA A/S is a Public limited company (A/S), founded on , based in Vallensbæk Strand. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.6% over the next 12 months, which is 0.4 times the average for Danish companies. 20 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Mar 2026) shows equity of DKK 456.5m and a net result of DKK 88.6m. CEO: Enor Cerimagic.
Bankruptcy risk for TAKEDA PHARMA A/S
0.4 × the average (1.41%) · higher risk than 66% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 16406899
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (42 years)
- Address
- Delta Park 45
2665 Vallensbæk Strand - Municipality
- Vallensbæk
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 10.1m
- Employees
- 209 (2018)
- Auditor
- KPMG P/S
- Audit opted out
- No
Warning signs
| Annual reports filed late | 2 of 24 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 73.2% |
| Current ratio | 379% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 8 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 11 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2026 | 2025 | 2024 |
|---|---|---|---|
| Revenue | DKK 1.1bn | DKK 1.1bn | DKK 1.1bn |
| Gross profit | DKK 215.7m | DKK 119.0m | DKK 437.7m |
| Net profit | DKK 88.6m | DKK 12.2m | DKK 261.2m |
| Equity | DKK 456.5m | DKK 368.3m | DKK 356.0m |
| Total assets | DKK 623.5m | DKK 581.3m | DKK 582.4m |
| Cash | DKK 2,000 | DKK 2,000 | – |
| Short-term debt | DKK 161.7m | DKK 203.7m | – |
| Tax owed | DKK 0 | DKK 0 | – |
| Avg. employees | 68 | 68 | – |
Latest annual report: Reporting class C, stor virksomhed · auditor's statement: Independent Auditor’s Report · KPMG Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Apr 2025 – 31 Mar 2026 | 171 | ||
| 1 Apr 2024 – 31 Mar 2025 | 169 | ||
| 1 Apr 2023 – 31 Mar 2024 | 164 | ||
| 1 Apr 2022 – 31 Mar 2023 | 182 | ||
| 1 Apr 2021 – 31 Mar 2022 | 181 | ||
| 1 Apr 2020 – 31 Mar 2021 | 167 | ||
| 1 Apr 2019 – 31 Mar 2020 | 248 | Late | |
| 1 Apr 2018 – 31 Mar 2019 | 162 | ||
| 1 Apr 2017 – 31 Mar 2018 | 152 | ||
| 1 Apr 2016 – 31 Mar 2017 | 152 | ||
| 1 Apr 2015 – 31 Mar 2016 | 153 | ||
| 1 Apr 2014 – 31 Mar 2015 | 154 | ||
| 1 Apr 2013 – 31 Mar 2014 | 168 | ||
| 1 Apr 2012 – 31 Mar 2013 | 162 | ||
| 1 Jan 2011 – 31 Dec 2011 | 177 | ||
| 1 Jan 2010 – 31 Dec 2010 | 96 | ||
| 1 Jan 2009 – 31 Dec 2009 | 151 | ||
| 1 Jan 2008 – 31 Dec 2008 | 172 | ||
| 1 Jan 2007 – 31 Dec 2007 | 155 | ||
| 1 Jan 2006 – 31 Dec 2006 | 176 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Enor Cerimagic | Current | |
| CEO | Anne Bagger Hansen | ||
| CEO | Bent Sørensen Kjærsgaard | ||
| CEO | Georgios Faidon Kalomoiris | ||
| CEO | Koki Sato | ||
| Board | Jesper Lindahl | Current | |
| Board | Enor Cerimagic | Current | |
| Board | Malene Kelstrup | Current | |
| Board | Koki Sato | Current | |
| Board | Jørgen Moestrup | ||
| Board | Helge Tovborg-Jensen | ||
| Board | Georg Dedichen | ||
| Board | Ole Tovborg Jensen | ||
| Board | Peter John Kielgast | ||
| Board | Bodil Kock Strøh | ||
| Board | Preben Reimer | ||
| Board | Bent Kersgaard Christiansen Løber | ||
| Board | Gert Juul | ||
| Board | Bent Eichstedt Nielsen | ||
| Board | Carsten Martini Nielsen | ||
| Board | Dorte Bøgelund | ||
| Board | Susanne Wollesen | ||
| Board | Anette Larsen | ||
| Board | Grethe Inger Suhr | ||
| Board | Birthe Gudrun Eriksen | ||
| Board | Henrik Kjeldsen | ||
| Board | Bjørn Ivar Flatgård | ||
| Board | Øyvin Anders Brøymer | ||
| Board | Bjørn Jensen | ||
| Board | Tore Talseth | ||
| Board | Olav Land | ||
| Board | Trond Vegard Jacobsen | ||
| Board | Helge Lund | ||
| Board | Helle Kit Knudsen | ||
| Board | Alejandra Maria Cristina Bonifacini Mørk | ||
| Board | Ole Nielsen | ||
| Board | Henrik Kjeldsen | ||
| Board | Birthe Gudrun Eriksen | ||
| Board | Leonard Ferdinand Gerard Detz | ||
| Board | Petter Homdrum | ||
| Board | Runar Bjørklund | ||
| Board | Britt Wolden | ||
| Board | Bo Thomas Dybbro | ||
| Board | Conny Ditlevsen | ||
| Board | Carsten Martini Nielsen | ||
| Board | Henrik Kjeldsen | ||
| Board | Thor-Björn Gunnar Conradsson | ||
| Board | Charles Albert Depasse | ||
| Board | Petter Homdrum | ||
| Board | Sven Håkan Björklund | ||
| Board | Thompson Dean | ||
| Board | Reid Samuel Perper | ||
| Board | Chinh Phu Chu | ||
| Board | Harry James Wilson | ||
| Board | Edward Richard Roberts | ||
| Board | Conny Ditlevsen | ||
| Board | Henrik Kjeldsen | ||
| Board | Thor-Björn Gunnar Conradsson | ||
| Board | Charles Albert Depasse | ||
| Board | Petter Homdrum | ||
| Board | Jesper Christian Schrøder | ||
| Board | Carsten Martini Nielsen | ||
| Board | Ulf Erik Strindholm | ||
| Board | Runar Bjørklund | ||
| Board | Ghita Astrup | ||
| Board | Bent Sørensen Kjærsgaard | ||
| Board | Marianne Hauge | ||
| Board | Carsten Martini Nielsen | ||
| Board | Marianne Jacobsen | ||
| Board | Jørgen Dahl | ||
| Board | Rickard Erik Söderberg | ||
| Board | Marianne Jacobsen | ||
| Board | Dominic Peter Moorhead | ||
| Board | Satoru Noguchi | ||
| Board | Helle Skov Wagner | ||
| Board | Gilbert Wilhelm Rademacher | ||
| Board | Susanne Munk | ||
| Board | Kirsten Betina Kjær Christensen | ||
| Board | Lise Bredahl Hervik Harre | ||
| Board | Lisbet Rankløve | ||
| Board | Ghita Astrup | ||
| Board | Dennis-Oliver Lauth | ||
| Board | Bjarne Mejlstrup Lange | ||
| Board | Marianne Jacobsen | ||
| Board | Bjarne Mejlstrup Lange | ||
| Board | Jesper Lindahl | ||
| Board | Jean Luc Delay | ||
| Board | Niels Hansen | ||
| Board | Ingeborg Rossebø Borgheim | ||
| Board | Athinagoras Efthymios Giannoulis | ||
| Board | Christian Ramskov | ||
| Board | Gitte Hjelvang | ||
| Board | Duarte Joao Lourinho Marchand | ||
| Board | Vatroslav Mateljic | ||
| Board | Koki Sato | ||
| Board | Christian Ramskov | ||
| Board | Koki Sato | ||
| Owner (100%) | Takeda Pharmaceuticals International AG | Current | |
| Owner (100%) | TAKEDA A/S | ||
| Auditor | KPMG P/S | Current | |
| Auditor | CJ Partnership I/S | ||
| Auditor | ANDERSEN STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | EY Danmark A/S | ||
| Auditor | DELOITTE STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | DELOITTE BUSINESS CONSULTING A/S | ||
| Auditor | ERNST & YOUNG DENMARK P/S | ||
| Auditor | EY Godkendt Revisionspartnerselskab |
The CEOs' other companies
Anne Bagger Hansen – 12 other companies, of which 3 bankrupt
- AKTIESELSKABET ROSCO Bankrupt 14 Oct 2024
- ECOBALANCE ApS Bankrupt 13 Apr 2011
- ROSCO EJENDOMME A/S Bankrupt 20 Feb 2026
- BENZON PHARMA A/S Fusioneret
- LÆGERNES BANK A/S Active
- NC AF 21/12 1990 A/S Opløst
- NYCOMED A/S Fusioneret
- NYCOMED PHARMA A/S Fusioneret
- NYCOMED PHARMA-MEDICA A/S Fusioneret
- ROSCO HOLDING ApS Active
- Rosco Diagnostica ApS Active
- TJELLESEN MAX JENNE A/S Active
Bent Sørensen Kjærsgaard – 17 other companies, of which 1 bankrupt
- ECOBALANCE ApS Bankrupt 13 Apr 2011
- BENZON PHARMA A/S Fusioneret
- BIBAWO Medical A/S Active
- DLI - DANSK LÆGEMIDDEL INFORMATION A/S Active
- DOC ApS Active
- DOC-BIBAWO ApS Fusioneret
- INFOMATUM A/S Opløst
- MEDILINK A/S Active
- NETTOPHARMA ApS Opløst
- NYCO HOLDINGS 2 ApS Fusioneret
- NYCO HOLDINGS 3 ApS Fusioneret
- NYCO HOLDINGS ApS Fusioneret
- NYCOMED A/S Fusioneret
- NYCOMED HOLDING ApS Fusioneret
- NYCOMED PHARMA A/S Fusioneret
- NYCOMED PHARMA-MEDICA A/S Fusioneret
- TAKEDA A/S Opløst
Address history (2 moves)
| Delta Park 45, 2665 Vallensbæk Strand | |
| Dybendal Alle 10, 2630 Taastrup | |
| Langebjerg 1, 4000 Roskilde |
Former names
| TAKEDA PHARMA A/S | – now |
| NYCOMED DANMARK ApS | – |
| NYCOMED DANMARK A/S | – |
| NYCOMED DAK A/S | – |
| DAK-LABORATORIET A/S | – |
Employees per year
Other companies at the same address
- Advanced Bionics Denmark ApS Active
- DALOC DANMARK A/S Active
- Dr. Reddy's Denmark ApS Active
- NutraQ ApS Active
- ORKLA FOODS DANMARK A/S Active
- ORKLA HOUSE CARE DANMARK A/S Active
- Orkla Foods Management ApS Active
- Orkla Natural Solutions A/S Opløst
- Saftkompagniet A/S Opløst
- Shire Denmark A/S Fusioneret
- VESTERÅLENS NATURPRODUKTER ApS Fusioneret
Similar companies in Vallensbæk
- Haleon Denmark ApS Vallensbæk Strand
- 2San ApS Vallensbæk
- GLAXOSMITHKLINE PHARMA A/S Vallensbæk Strand
- PREPPERZ ApS Vallensbæk Strand
- INTERMEDITECH ApS Vallensbæk Strand
Questions and answers about TAKEDA PHARMA A/S
Has TAKEDA PHARMA A/S gone bankrupt?
No, TAKEDA PHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of TAKEDA PHARMA A/S?
Our model estimates a bankruptcy risk of 0.6% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of TAKEDA PHARMA A/S?
Enor Cerimagic is the CEO of TAKEDA PHARMA A/S.
Who is the auditor of TAKEDA PHARMA A/S?
TAKEDA PHARMA A/S most recently used KPMG P/S.
When was TAKEDA PHARMA A/S founded?
TAKEDA PHARMA A/S was founded on 2 January 1984.
What is the equity of TAKEDA PHARMA A/S?
Equity was DKK 456.5m according to the annual report for the period ending 31 March 2026.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.